OBJECTIVES: We compared completion rates for adolescent immunization series administered at school-based health centers (SBHCs) to completion rates for series administered at community health centers (CHCs) within a single integrated delivery system. METHODS: We performed a retrospective analysis of data from an immunization registry for patients aged 12-18 years. Patients were assigned to either an SBHC or a CHC during the study interval based on utilization. We used bivariate analysis to compare immunization series completion rates between the 2 groups and multivariate analysis to compare risk factors for underimmunization. We performed subanalyses by ages 12-15 years versus ages 16-18 years for human papillomavirus (HPV) and for the combination of HPV; tetanus, diptheria, and pertussis (Tdap); and tetravalent meningococcus virus. RESULTS: SBHC users had significantly higher completion rates (P<.001) for hepatitis B, Tdap, inactivated poliovirus, varicella, measles/mumps/rubella, and HPV for ages 16-18 years, and for the combination of HPV, Tdap, and MCV4 for ages 16-18 years. CHC users had higher completion rates for tetanus and diphtheria. CONCLUSIONS: SBHCs had higher completion rates than did CHCs for immunization series among those aged 12-18 years, despite serving a population with limited insurance coverage.
OBJECTIVES: We compared completion rates for adolescent immunization series administered at school-based health centers (SBHCs) to completion rates for series administered at community health centers (CHCs) within a single integrated delivery system. METHODS: We performed a retrospective analysis of data from an immunization registry for patients aged 12-18 years. Patients were assigned to either an SBHC or a CHC during the study interval based on utilization. We used bivariate analysis to compare immunization series completion rates between the 2 groups and multivariate analysis to compare risk factors for underimmunization. We performed subanalyses by ages 12-15 years versus ages 16-18 years for human papillomavirus (HPV) and for the combination of HPV; tetanus, diptheria, and pertussis (Tdap); and tetravalent meningococcus virus. RESULTS: SBHC users had significantly higher completion rates (P<.001) for hepatitis B, Tdap, inactivated poliovirus, varicella, measles/mumps/rubella, and HPV for ages 16-18 years, and for the combination of HPV, Tdap, and MCV4 for ages 16-18 years. CHC users had higher completion rates for tetanus and diphtheria. CONCLUSIONS: SBHCs had higher completion rates than did CHCs for immunization series among those aged 12-18 years, despite serving a population with limited insurance coverage.
Authors: Allison Kempe; Brenda L Beaty; John F Steiner; Kellyn A Pearson; N Elaine Lowery; Matthew F Daley; Lori A Crane; Stephen Berman Journal: Am J Public Health Date: 2004-06 Impact factor: 9.308
Authors: R R Deuson; E J Hoekstra; R Sedjo; G Bakker; P Melinkovich; D Daeke; A L Hammer; D Goldsman; F N Judson Journal: Am J Public Health Date: 1999-11 Impact factor: 9.308
Authors: Stanley J Schaffer; John Fontanesi; Donna Rickert; John D Grabenstein; Mitchel C Rothholz; Susan A Wang; Daniel Fishbein Journal: Pediatrics Date: 2008-01 Impact factor: 7.124
Authors: Karen R Broder; Amanda C Cohn; Benjamin Schwartz; Jonathan D Klein; Martin M Fisher; Daniel B Fishbein; Christina Mijalski; Gale R Burstein; Mary E Vernon-Smiley; Mary M McCauley; Charles J Wibbelsman Journal: Pediatrics Date: 2008-01 Impact factor: 7.124
Authors: Peter G Szilagyi; Cynthia M Rand; Jennie McLaurin; Litjen Tan; Maria Britto; Anne Francis; Eileen Dunne; Donna Rickert Journal: Pediatrics Date: 2008-01 Impact factor: 7.124
Authors: Cynthia M Rand; Laura P Shone; Christina Albertin; Peggy Auinger; Jonathan D Klein; Peter G Szilagyi Journal: Arch Pediatr Adolesc Med Date: 2007-03
Authors: Glenn Flores; Elena Fuentes-Afflick; Oxiris Barbot; Olivia Carter-Pokras; Luz Claudio; Marielena Lara; Jennie A McLaurin; Lee Pachter; Francisco J Ramos-Gomez; Fernando Mendoza; R Burciaga Valdez; Antonia M Villarruel; Ruth E Zambrana; Robert Greenberg; Michael Weitzman; Francisco J Ramos Gomez Journal: JAMA Date: 2002-07-03 Impact factor: 56.272
Authors: Mandy A Allison; Lori A Crane; Brenda L Beaty; Arthur J Davidson; Paul Melinkovich; Allison Kempe Journal: Pediatrics Date: 2007-09-10 Impact factor: 7.124
Authors: Parth D Shah; Melissa B Gilkey; Jessica K Pepper; Sami L Gottlieb; Noel T Brewer Journal: Expert Rev Vaccines Date: 2014-01-03 Impact factor: 5.217
Authors: John A Knopf; Ramona K C Finnie; Yinan Peng; Robert A Hahn; Benedict I Truman; Mary Vernon-Smiley; Veda C Johnson; Robert L Johnson; Jonathan E Fielding; Carles Muntaner; Pete C Hunt; Camara Phyllis Jones; Mindy T Fullilove Journal: Am J Prev Med Date: 2016-07 Impact factor: 5.043
Authors: Stuart Cowburn; Matthew Carlson; Jodi Lapidus; John Heintzman; Steffani Bailey; Jennifer DeVoe Journal: Am J Public Health Date: 2014-07-17 Impact factor: 9.308
Authors: Sion K Harris; Matthew C Aalsma; Elissa R Weitzman; Diego Garcia-Huidobro; Charlene Wong; Scott E Hadland; John Santelli; M Jane Park; Elizabeth M Ozer Journal: J Adolesc Health Date: 2016-12-20 Impact factor: 5.012